Drug research and development opportunities in low- and middle-income countries: accelerating traditional medicine through systematic utilization and comprehensive synergy
Tóm tắt
Though the utilization of traditional medicine has been proposed for modern drug research and development (R&D), limited research has discussed its feasible paths. In this commentary, we summarized key factors for new drug R&D under limited resources by reviewing China’s discovery of artemisinin, and raised suggestions to utilize traditional medicines in low- and middle-income countries (LMICs). We suggested that systematic utilization of traditional medicine, outstanding synergy of research units at all levels and timely information-sharing mechanism should be achieved to establish a comprehensive and efficient R&D system, especially under low-resource settings. In the case of artemisinin discovery, Chinese scientists integrated documented traditional medicine experiences and modern approaches to develop drug candidates timely. Due to limited R&D resources, China adopted a collaborative way, motivating nearly all domestic research units at different levels, to develop antimalarial products. Moreover, the excellent synergy among all units through efficient information-sharing mechanisms greatly avoided work repetition and accelerated the R&D process. Traditional medicines inspires drug discoveries in LMICs, while a comprehensive and efficient R&D system could accelerate its R&D process and save investment. The discovery of artemisinin in China gave a reliable pattern to promote sustainable development of traditional medicines and a good example to realize R&D of traditional medicine under low-resource settings.
Tài liệu tham khảo
Abbo C, Odokonyero R, Ovuga E. A narrative analysis of the link between modern medicine and traditional medicine in Africa: a case of mental health in Uganda. Brain Res Bull. 2019;145:109–16.
Zhu Z, Wang T, Fu D, Gui Y, Wang J, Cui T. Innovative development path of ethnomedicines: an overview of ethnomedicines in China. Front Med. 2016;10(2):166–77.
Programme on Traditional Medicine. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. Geneva: World Health Organization; 2001.
Lam WC, Lyu A, Bian Z. ICD-11: Impact on traditional chinese medicine and world healthcare systems. Pharm Med. 2019;33(5):373–7.
Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21:5.
Zhu Z, Gui Y, Wang L, Wang T, Yang Y, Niu Y, et al. Innovative development path of ethnomedicines: a case study. Front Med. 2017;11(2):297–305.
Abdullahi AA. Trends and challenges of traditional medicine in Africa. Afr J Tradit Complement Altern Med. 2011;8(Suppl 5):115–23.
Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009;14(15–16):804–11.
Li Q, Wang H, Li X, Zheng Y, Wei Y, Zhang P, et al. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China. Front Med. 2020;14(5):681–8.
Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17(10):1217–20.
World Health Organization. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2006.
Williams CT. Food and drug administration drug approval process: a history and overview. Nurs Clin North Am. 2016;51(1):1–11.
Tan J, Wan F, Tan C. The application history of Qinghao as medicine and food [Qinghao Yao Yong Shi Yong Li Shi Kao Lue]. Asia-Pacific Tradit Med. 2020;16(8):75–6.
Tu Y, Luo Z, Li G, Zhang J, Wu Z, Shi B, et al. Interveiws on 523 project and the discovery of artemisinin [523 Renwu Yu Qinghaosu Yanfa Fangtanlu]. Hunan: Hunan Education Publishing House; 2015.